BIO-B: the balance sheet

MyFinsight

For the year ending 2025-12-31, BIO-B has $10,576,500K in assets. $3,122,900K in debts. $529,800K in cash and cash equivalents.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Balance Sheets	2025-12-31
Cash and cash equivalents	529,800
Short-term investments	1,010,900
Restricted investments	460,600
Inventory	740,700
Prepaid expenses	136,500
Other current assets	27,700
Total current assets	2,906,200
Property, plant and equipment, net	539,900
Operating lease right-of-use assets	170,000
Goodwill, net	579,800
Purchased intangibles, net	174,300
Other investments	6,103,600
Other assets	102,700
Total assets	10,576,500

Accounts payable	129,000
Accrued payroll and employee benefits	172,300
Current maturities of long-term debt and notes payable	1,300
Income and other taxes payable	36,600
Current operating lease liabilities	36,100
Other current liabilities	141,700
Total current liabilities	517,000
Long-term debt, net of current maturities	1,201,700
Deferred income taxes	1,059,400
Operating lease liabilities	145,700
Other long-term liabilities	199,100
Total liabilities	3,122,900
Preferred stock	0
Common stock-Common Class A	0
Common stock-Common Class B	0
Additional paid-in capital	476,000
Class a treasury stock at cost, 3,275,476 shares at 2025 and 2,254,728 shares at 2024	1,009,600
Retained earnings	8,176,300
Accumulated other comprehensive loss	-189,100
Total stockholders equity	7,453,600
Total liabilities and stockholders equity	10,576,500

Unit: Thousand (K) dollars